Predict your next investment


See what CB Insights has to offer

Founded Year



Series A | Alive

Total Raised


Last Raised

$3.06M | 9 yrs ago

About Everist Genomics

Provider and developer of diagnostics, prognostics, and therapeutic selection technologies. The company's focus is on diseases including cancer, cardiovascular disease, and metabolic disease, such as diabetes. The products integrate with mobile digital services, smartphones, and tablet computers. [Keywords: personalized medicine, oncology, drug rescue, companion diagnostics]

Everist Genomics Headquarter Location

709 West Ellsworth Road

Ann Arbor, Michigan, 48108,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Everist Genomics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Everist Genomics is included in 2 Expert Collections, including Diabetes.



1,749 items



5,732 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.